Breaking News Instant updates and real-time market news.

BTAI

BioXcel Therapeutics

$9.95

0.075 (0.76%)

, NKTR

Nektar

$85.79

2.38 (2.85%)

08:16
05/17/18
05/17
08:16
05/17/18
08:16

BioXcel announces data presentation at ASCO annual meeting

BioXcel Therapeutics (BTAI) announced that it will present a poster featuring data from a preclinical study of the company's BXCL-701 and Nektar Therapeutics' (NKTR) NKTR-214 as a potential combination therapy for pancreatic cancer patients at the upcoming 2018 American Society for Clinical Oncology, or ASCO, Annual Meeting, being held June 1-5, 2018 in Chicago, IL, USA.

BTAI

BioXcel Therapeutics

$9.95

0.075 (0.76%)

NKTR

Nektar

$85.79

2.38 (2.85%)

  • 21

    May

  • 21

    May

  • 12

    Jun

BTAI BioXcel Therapeutics
$9.95

0.075 (0.76%)

04/02/18
ADAM
04/02/18
INITIATION
Target $21
ADAM
Buy
BioXcel Therapeutics initiated with a Buy at Canaccord
Canaccord analyst Sumant Kulkarni initiated BioXcel Therapeutics with a Buy rating and $21 price target citing its uncommon systematic AI approach and several upcoming catalysts he sees coming in the second half of 2018 and 2019.
04/02/18
04/02/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Karyopharm (KPTI) assumed with an Outperform at Leerink. 2. BioXcel Therapeutics (BTAI) was initiated with a Buy at Canaccord and UBS, an Outperform at BMO Capital, and an Overweight at Barclays. 3. New York & Co. (NWY) initiated with a Buy at Roth Capital. 4. Sellas Life Sciences (SLS) initiated with a Buy at H.C. Wainwright. 5. Hanesbrands (HBI) initiated with a Neutral at Macquarie. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/03/18
HCWC
05/03/18
INITIATION
Target $25
HCWC
Buy
BioXcel Therapeutics initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started BioXcel Therapeutics with a Buy rating and $25 price target. The analyst believes BXCL701 could be incorporated into multiple future I/O combination regimens.
05/03/18
05/03/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. nVent Electric (NVT) initiated with a Neutral at Goldman Sachs and a Perform at Oppenheimer. 2. Apergy (APY) initiated with an Outperform at Evercore ISI. 3. BioXcel Therapeutics (BTAI) initiated with a Buy at H.C. Wainwright. 4. CytRx (CYTR) assumed with a Buy at H.C. Wainwright. 5. Lithium Americas (LAC) initiated with a Buy at Roth Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
NKTR Nektar
$85.79

2.38 (2.85%)

05/11/18
PIPR
05/11/18
NO CHANGE
Target $125
PIPR
Overweight
Piper expects positive oral presentation from Nektar in early June
Piper Jaffray analyst Tyler Van Buren believes next Wednesday's ASCO abstract for Nektar's Phase I/II Pivot study of NKTR-214 in combination with nivolumab will be one of the most highly anticipated abstracts of the conference. The analyst notes, however, that the abstract will be from a February data cut while the oral presentation in early June will be from a data cut later this month. As such, the oral presentation will contain "significantly more mature data and should ultimately be relied on to make conclusions about the anti-tumor activity," Van Buren tells investors in a research note. He believes the oral presentation will be positive and keeps an Overweight rating on Nektar Therapeutics with a $125 price target following the company's Q1 results.
05/14/18
HCWC
05/14/18
NO CHANGE
Target $125
HCWC
Buy
Nektar pullbacks 'could get compelling,' says H.C. Wainwright
H.C. Wainwright analyst Debjit Chattopadhyay said ASCO abstracts featuring data from Nektar's ongoing PIVOT-02 study have potentially reset expectations, but he also noted that the actual podium presentation is likely to include an updated cut of data from up to late May. The analyst, who thinks pullbacks in Nektar Therapeutics shares "could get compelling," maintains a Buy rating and $125 price target on the stock.
05/16/18
PIPR
05/16/18
NO CHANGE
Target $125
PIPR
Overweight
Nektar 214+nivo response for melanoma not conclusive, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren keeps his Overweight rating and $125 price target on Nektar (NKTR) after the release of PIVOT ASCO abstract of NKTR 214+nivo (BMY). The analyst says that while the 1L melanoma response rate may be "slightly lower than some had hoped for", the 1L RCC response rate were "nicely above" what has been seen with ipi+nivo treatment. Van Buren adds that while small in numbers, "3/4 responses in 1L bladder and 1/3 responses in triple negative breast cancer are encouraging." The analyst believes that the stock may be down in the morning, but investors should not come to "rash conclusions", as the ASCO presentation with more patients and detail is likely to be positive.
05/17/18
JPMS
05/17/18
NO CHANGE
JPMS
Nektar may sell off modestly on ASCO abstract, says JPMorgan
JPMorgan analyst Jessica Fye says that consistent with her expectation heading into last night's abstracts, Nektar Therapeutics' NKTR-214 update was not definitive as it relates to the ultimate profile for the product. Management emphasized in advance that follow up would be limited for the new patients in the abstract, and this was "abundantly evident" with 22 of the 30 Phase II patients having had only one scan, Fye tells investors in a research note. Overall, the analyst sees "bright spots" in the abstract from signs of durable responses, tolerability, and an "intriguing" signal in bladder cancer. She notes, however, that some investors will pick at the decreased overall response rates in the new patients in melanoma, renal cell carcinoma and lung. While the limited follow up in the abstract was well-telegraphed, Nektar shares trading modestly lower today would not be surprising, Fye writes. The analyst keeps an Overweight rating on the stock.

TODAY'S FREE FLY STORIES

VSAT

ViaSat

$61.75

-1.08 (-1.72%)

09:03
05/25/18
05/25
09:03
05/25/18
09:03
Recommendations
ViaSat analyst commentary  »

ViaSat price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CCL

Carnival

$64.15

-0.02 (-0.03%)

09:02
05/25/18
05/25
09:02
05/25/18
09:02
Recommendations
Carnival analyst commentary  »

Carnival capacity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

GVA

Granite Construction

$57.18

-0.48 (-0.83%)

09:01
05/25/18
05/25
09:01
05/25/18
09:01
Recommendations
Granite Construction analyst commentary  »

Granite Construction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$22.26

-0.205 (-0.91%)

08:58
05/25/18
05/25
08:58
05/25/18
08:58
Technical Analysis
Technical Take: Fiat Chrysler falls on 4.8M vehicle U.S.-market recall »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BKE

The Buckle

$25.75

0.65 (2.59%)

08:55
05/25/18
05/25
08:55
05/25/18
08:55
Technical Analysis
Technical Take: The Buckle slides lower after reporting earnings »

In the pre-market the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

BAC

Bank of America

$30.19

-0.26 (-0.85%)

, PBR

Petrobras

$12.77

-2.335 (-15.46%)

08:55
05/25/18
05/25
08:55
05/25/18
08:55
Options
Notable open interest changes for May 25th »

Thursday's total…

BAC

Bank of America

$30.19

-0.26 (-0.85%)

PBR

Petrobras

$12.77

-2.335 (-15.46%)

AAPL

Apple

$188.18

-0.18 (-0.10%)

AFSI

AmTrust

$13.73

-0.045 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

ROST

Ross Stores

$82.95

0.35 (0.42%)

08:52
05/25/18
05/25
08:52
05/25/18
08:52
Technical Analysis
Technical Take: Ross Stores falls after earnings »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPS

Gap

$32.97

1 (3.13%)

, FL

Foot Locker

$46.38

1.35 (3.00%)

08:52
05/25/18
05/25
08:52
05/25/18
08:52
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Amarin (AMRN), up…

GPS

Gap

$32.97

1 (3.13%)

FL

Foot Locker

$46.38

1.35 (3.00%)

DECK

Deckers Brands

$103.63

0.8 (0.78%)

HIBB

Hibbett Sports

$28.95

0.6 (2.12%)

AMRN

Amarin

$3.04

0.04 (1.33%)

TEVA

Teva

$21.64

0.485 (2.29%)

BMRN

BioMarin

$88.30

-0.2 (-0.23%)

ZOES

Zoe's Kitchen

$14.48

-0.41 (-2.75%)

EGHT

8x8, Inc.

$22.00

0.35 (1.62%)

ADSK

Autodesk

$138.76

-0.54 (-0.39%)

SPLK

Splunk

$116.35

-0.2 (-0.17%)

CBB

Cincinnati Bell

$15.93

-0.225 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

  • 25

    May

  • 25

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 12

    Jun

  • 14

    Jun

  • 16

    Jun

  • 10

    Jul

  • 12

    Sep

LOMA

Loma Negra

$11.52

-1.47 (-11.32%)

08:51
05/25/18
05/25
08:51
05/25/18
08:51
Upgrade
Loma Negra rating change  »

Loma Negra upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LOMA

Loma Negra

$11.52

-1.47 (-11.32%)

08:50
05/25/18
05/25
08:50
05/25/18
08:50
Hot Stocks
Loma Negra says not under investigation in Argentina for cartelization »

Loma Negra said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

, SPX

S&P 500

$0.00

(0.00%)

08:49
05/25/18
05/25
08:49
05/25/18
08:49
General news
Trump says 'time will tell' after 'warm and productive' North Korean statement »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$272.87

-0.5 (-0.18%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$53.85

-0.14 (-0.26%)

08:47
05/25/18
05/25
08:47
05/25/18
08:47
Hot Stocks
Herbalife Nutrition announces preliminary results of self-tender offer »

Herbalife Nutrition…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$22.26

-0.205 (-0.91%)

08:46
05/25/18
05/25
08:46
05/25/18
08:46
Hot Stocks
Fiat Chrysler recalls estimated 4.8M U.S.-market vehicles for software upgrade »

FCA US announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:45
05/25/18
05/25
08:45
05/25/18
08:45
Conference/Events
Federal Reserve Chairman Powell participates in a panel discussion »

Federal Reserve Chairman…

NOK

Nokia

$6.09

-0.01 (-0.16%)

, AAOI

Applied Optoelectronics

$33.91

0.24 (0.71%)

08:45
05/25/18
05/25
08:45
05/25/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

NOK

Nokia

$6.09

-0.01 (-0.16%)

AAOI

Applied Optoelectronics

$33.91

0.24 (0.71%)

MDXG

MiMedx

$8.86

-0.12 (-1.34%)

GERN

Geron

$4.81

0.14 (3.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

08:45
05/25/18
05/25
08:45
05/25/18
08:45
General news
Treasury Action: yields remained at low ebb »

Treasury Action: yields…

08:35
05/25/18
05/25
08:35
05/25/18
08:35
General news
U.S. durable goods orders fell 1.7% in April »

U.S. durable goods orders…

TIF

Tiffany

$126.44

0.3 (0.24%)

08:34
05/25/18
05/25
08:34
05/25/18
08:34
Recommendations
Tiffany analyst commentary  »

Tiffany price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

DECK

Deckers Brands

$103.63

0.8 (0.78%)

08:34
05/25/18
05/25
08:34
05/25/18
08:34
Technical Analysis
Technical Take: Deckers at new 52-week high after earnings, analyst action »

The company reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USNA

USANA

$116.75

-2.85 (-2.38%)

08:34
05/25/18
05/25
08:34
05/25/18
08:34
Hot Stocks
USANA clinical sciences team to be led by Rolando Maddela, Jessie Johnson »

USANA is announcing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WB

Weibo

$102.36

-1.08 (-1.04%)

08:33
05/25/18
05/25
08:33
05/25/18
08:33
Recommendations
Weibo analyst commentary  »

Weibo risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HWC

Hancock Whitney Corporation

$51.60

-0.2 (-0.39%)

, BBRG

Bravo Brio Restaurant

$4.05

(0.00%)

08:30
05/25/18
05/25
08:30
05/25/18
08:30
Options
One new option listing and two option delistings on May 25th »

New option listings for…

HWC

Hancock Whitney Corporation

$51.60

-0.2 (-0.39%)

BBRG

Bravo Brio Restaurant

$4.05

(0.00%)

HBHC

Symbol changed to HWC

$51.60

-0.2 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:30
05/25/18
05/25
08:30
05/25/18
08:30
General news
Fed Chairman Powell will make an appearance »

Fed Chairman Powell will…

SPLK

Splunk

$116.35

-0.2 (-0.17%)

08:28
05/25/18
05/25
08:28
05/25/18
08:28
Recommendations
Splunk analyst commentary  »

Splunk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

FL

Foot Locker

$46.38

1.35 (3.00%)

08:27
05/25/18
05/25
08:27
05/25/18
08:27
Technical Analysis
Technical Take: Foot Locker sharply higher after earning beat, outlook »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.